CN104817519B - 一类ca-4的衍生物、其制法及其医药用途 - Google Patents
一类ca-4的衍生物、其制法及其医药用途 Download PDFInfo
- Publication number
- CN104817519B CN104817519B CN201510235806.3A CN201510235806A CN104817519B CN 104817519 B CN104817519 B CN 104817519B CN 201510235806 A CN201510235806 A CN 201510235806A CN 104817519 B CN104817519 B CN 104817519B
- Authority
- CN
- China
- Prior art keywords
- acid
- arh
- compound
- ethyl acetate
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510235806.3A CN104817519B (zh) | 2015-05-11 | 2015-05-11 | 一类ca-4的衍生物、其制法及其医药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510235806.3A CN104817519B (zh) | 2015-05-11 | 2015-05-11 | 一类ca-4的衍生物、其制法及其医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104817519A CN104817519A (zh) | 2015-08-05 |
CN104817519B true CN104817519B (zh) | 2016-11-16 |
Family
ID=53728020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510235806.3A Active CN104817519B (zh) | 2015-05-11 | 2015-05-11 | 一类ca-4的衍生物、其制法及其医药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104817519B (it) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109006694A (zh) * | 2018-08-15 | 2018-12-18 | 广州星燎生物科技有限公司 | 一种肝癌鸡胚绒毛尿囊膜m-cdx模型的建立方法 |
CN108990900A (zh) * | 2018-08-15 | 2018-12-14 | 广州星燎生物科技有限公司 | 一种肺癌鸡胚绒毛尿囊膜m-cdx模型及制备方法 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006138427A2 (en) * | 2005-06-14 | 2006-12-28 | Baylor University | Combretastatin analogs with tubulin binding activity |
WO2009118474A1 (fr) * | 2008-02-28 | 2009-10-01 | Sanofi-Aventis | Procede de preparation de combretastatine |
EP2338877A1 (en) * | 2009-12-15 | 2011-06-29 | The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin | Combretastatin Derivatives and Uses Therefor |
CN102219811A (zh) * | 2011-04-14 | 2011-10-19 | 中国药科大学 | Ca-4衍生物、其制法及其医药用途 |
CN102249987A (zh) * | 2011-05-06 | 2011-11-23 | 兰州大学 | 一种考布他汀类化合物及其制备方法和用途 |
CN102863472A (zh) * | 2012-10-15 | 2013-01-09 | 中国海洋大学 | 考布他汀a-4类似物及其制备方法和在制备抗肿瘤药物中的应用 |
CN102906076A (zh) * | 2009-12-03 | 2013-01-30 | 赛诺菲 | 考布他汀衍生物制备方法 |
WO2013026942A1 (en) * | 2011-08-25 | 2013-02-28 | The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Tubulin binding agents |
CN102985410A (zh) * | 2010-05-05 | 2013-03-20 | 拜罗伊特大学 | 在癌症的治疗中使用的考布他汀类似物 |
CN103421057A (zh) * | 2013-08-14 | 2013-12-04 | 合肥医工医药有限公司 | 康普瑞汀氨基糖缀合物、其制法及其医药用途 |
CN103524349A (zh) * | 2013-10-19 | 2014-01-22 | 山东大学 | Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途 |
WO2014181085A1 (en) * | 2013-05-09 | 2014-11-13 | Kenneth Dawson Bagshawe | Tumour therapy |
-
2015
- 2015-05-11 CN CN201510235806.3A patent/CN104817519B/zh active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006138427A2 (en) * | 2005-06-14 | 2006-12-28 | Baylor University | Combretastatin analogs with tubulin binding activity |
WO2009118474A1 (fr) * | 2008-02-28 | 2009-10-01 | Sanofi-Aventis | Procede de preparation de combretastatine |
CN102906076A (zh) * | 2009-12-03 | 2013-01-30 | 赛诺菲 | 考布他汀衍生物制备方法 |
EP2338877A1 (en) * | 2009-12-15 | 2011-06-29 | The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin | Combretastatin Derivatives and Uses Therefor |
CN102985410A (zh) * | 2010-05-05 | 2013-03-20 | 拜罗伊特大学 | 在癌症的治疗中使用的考布他汀类似物 |
CN102219811A (zh) * | 2011-04-14 | 2011-10-19 | 中国药科大学 | Ca-4衍生物、其制法及其医药用途 |
CN102249987A (zh) * | 2011-05-06 | 2011-11-23 | 兰州大学 | 一种考布他汀类化合物及其制备方法和用途 |
WO2013026942A1 (en) * | 2011-08-25 | 2013-02-28 | The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Tubulin binding agents |
CN102863472A (zh) * | 2012-10-15 | 2013-01-09 | 中国海洋大学 | 考布他汀a-4类似物及其制备方法和在制备抗肿瘤药物中的应用 |
WO2014181085A1 (en) * | 2013-05-09 | 2014-11-13 | Kenneth Dawson Bagshawe | Tumour therapy |
CN103421057A (zh) * | 2013-08-14 | 2013-12-04 | 合肥医工医药有限公司 | 康普瑞汀氨基糖缀合物、其制法及其医药用途 |
CN103524349A (zh) * | 2013-10-19 | 2014-01-22 | 山东大学 | Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途 |
Non-Patent Citations (1)
Title |
---|
考布他汀A-4衍生物CPU-XT-006对人脐静脉内皮细胞增殖、凋亡及VEGF、bFGF表达的影响;何书英,等;《中国药科大学学报》;20131231;第44卷(第5期);第451-454页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104817519A (zh) | 2015-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104583218B (zh) | 作为蛋白酶活化受体4(par4)抑制剂用于治疗血小板聚集的咪唑并噻二唑和咪唑并吡嗪的衍生物 | |
ES2320320T3 (es) | Nuevos compuestos de isoxazol y tiazol y uso de los mismos como farmacos. | |
CN101715450B (zh) | 作为cftr调控剂的氮杂吲哚衍生物 | |
CN109152933A (zh) | 诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途 | |
AU2015226855A1 (en) | Human plasma kallikrein inhibitors | |
ES2672992T3 (es) | Compuesto aromático | |
CN109476635A (zh) | 用于治疗疾病的二取代吡唑类化合物 | |
MXPA02007035A (es) | Compuesto ciclico conteniendo nitrogeno y composicion farmaceutica conteniendo el compuesto. | |
TW200404060A (en) | Fused heterocyclic compounds | |
CN109384782A (zh) | 取代五元并六元杂环类化合物、其制备方法、药物组合及其用途 | |
ES2773994T3 (es) | Inhibidores de grelina O-aciltransferasa | |
CN107151250A (zh) | 嘧啶类七元环化合物、其制备方法、药用组合物及其应用 | |
CA3090493A1 (en) | Substituted benzothiophene analogs as selective estrogen receptor degraders | |
CN101143845A (zh) | 取代喹啉甲酰胍衍生物、其制备方法及其医药用途 | |
CN105722835A (zh) | 3-芳基-5-取代的-异喹啉-1-酮化合物及它们的疗法应用 | |
BR112020014584A2 (pt) | inibição do canal iônico do receptor de potencial transitório a1 | |
PT1320526E (pt) | Derivados de sulfonamida activos a nível farmacêutico | |
CN106573907A (zh) | 新颖的喹啉衍生物及其用于神经退化性疾病的用途 | |
CN104817519B (zh) | 一类ca-4的衍生物、其制法及其医药用途 | |
CN108463222A (zh) | 用于治疗疾病的杂环化合物 | |
CN106573901A (zh) | 富马酸酯类似物及其在治疗自身免疫性疾病或炎性疾病中的用途 | |
CN106892920A (zh) | 苦豆碱衍生物、其制备方法及用途 | |
CN107207476A (zh) | 吲哚和氮杂吲哚衍生物及其用于神经退化性疾病中的用途 | |
CN105237444B (zh) | 异羟肟酸类化合物及其制备方法和用途 | |
CN106117182A (zh) | 喹唑啉‑n‑苯乙基四氢异喹啉类化合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |